AryoGen Pharmed

ERC Belgium is to continue to collect clinical trial data for Sitoiganap following its decision this month to pull the EU marketing application for the investigational autologous cell-based immunothe

The sponsors of 11 medicines should learn this week whether the European Medicines Agency will recommend that their products be granted pan-EU marketing authorization. They include Sanofi for its dr

Mobocertinib, Takeda Pharmaceutical ’s investigational, first-in-class treatment for certain patients with non-small cell lung cancer (NSCLC), is among the latest batch of products that the European